Literature DB >> 18400015

Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals.

Marta M Wroblewska1, Anna Sawicka-Grzelak, Halina Marchel, Miroslaw Luczak, Alex Sivan.   

Abstract

Microbial biofilms are considered as virulence factors. During the present study, 34 clinical strains of Acinetobacter baumannii, isolated from patients hospitalized in two tertiary care hospitals, were examined for biofilm formation. These strains showed high variability in biofilm formation. Furthermore, no relation could be found between the ability of biofilm production and molecular type, carbapenem resistance, site of isolation of the clinical strains of A. baumannii and disease severity. Interestingly, in two cases an increase in biofilm formation could be detected in A. baumannii isolates cultured from the same patient upon prolonged hospitalization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400015     DOI: 10.1111/j.1574-695X.2008.00403.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  19 in total

1.  Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii.

Authors:  Elisabetta Nucleo; Laura Steffanoni; Giulia Fugazza; Roberta Migliavacca; Ernesto Giacobone; Antonella Navarra; Laura Pagani; Paolo Landini
Journal:  BMC Microbiol       Date:  2009-12-22       Impact factor: 3.605

2.  Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.

Authors:  Ali Mohammadi Bardbari; Mohammad Reza Arabestani; Manoochehr Karami; Fariba Keramat; Hossein Aghazadeh; Mohammad Yousef Alikhani; Kamran Pooshang Bagheri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-20       Impact factor: 3.267

3.  Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties.

Authors:  Christin N McQueary; Luis A Actis
Journal:  J Microbiol       Date:  2011-05-03       Impact factor: 3.422

4.  The opportunistic human pathogen Acinetobacter baumannii senses and responds to light.

Authors:  María A Mussi; Jennifer A Gaddy; Matías Cabruja; Brock A Arivett; Alejandro M Viale; Rodolfo Rasia; Luis A Actis
Journal:  J Bacteriol       Date:  2010-10-01       Impact factor: 3.490

5.  The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool.

Authors:  Laure Diancourt; Virginie Passet; Alexandr Nemec; Lenie Dijkshoorn; Sylvain Brisse
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

6.  Combined Effects Of Low Incubation Temperature, Minimal Growth Medium, And Low Hydrodynamics Optimize Acinetobacter baumannii Biofilm Formation.

Authors:  Emmanuel C Eze; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2019-11-15       Impact factor: 4.003

7.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Authors:  Ignasi Roca; Paula Espinal; Xavier Vila-Farrés; Jordi Vila
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

8.  In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations.

Authors:  Joon Young Song; Hee Jin Cheong; Ji Yun Noh; Woo Joo Kim
Journal:  Infect Chemother       Date:  2015-03-30

9.  Iron and Acinetobacter baumannii Biofilm Formation.

Authors:  Valentina Gentile; Emanuela Frangipani; Carlo Bonchi; Fabrizia Minandri; Federica Runci; Paolo Visca
Journal:  Pathogens       Date:  2014-08-18

10.  Molecular detection of Extended-Spectrum β-lactamases (ESBLs) and biofilm formation in uropathogen Klebsiella pneumoniae in Iran.

Authors:  Elham Haghighifar; Fatemeh Norouzi; Razie Kamali Dolatabadi
Journal:  Med J Islam Repub Iran       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.